Rat data: Selank/Semax route differences (SubQ vs intranasal) + combo vs solo use

gurbert

gurbert

Recently Joined
🚫No Source Discussion🚫
Member Since
Jan 16, 2026
Posts
11
Likes Received
31
Location
Thailand
I’m compiling preclinical (lab rat) observations on Selank and Semax, and would really value input from researchers/experienced testers.

I’m specifically interested in:
  1. Route comparison: SubQ vs intranasal
  2. Compound strategy: Semax alone, Selank alone, vs combined (co-administered)
  3. Outcomes: behavioral/cognitive/anxiety-like effects, and any clear CNS-signaling differences
  4. Practicals: dose range, frequency, timing, washout, and whether route changed effect consistency
  5. Tolerability/signals: local irritation, stress response, habituation/tachyphylaxis, etc.
If you’ve run or seen rat work, I’d appreciate details like:
  • Strain/sex/age (useful but not necessary if your rat is shy)
  • Dosing protocol (mcg, schedule, duration)
  • Route and formulation
  • Whether combo was simultaneous or staggered
Not looking for medical advice, just trying to gather methodologically useful preclinical experience and compare notes across labs.

My current log: my rat is on day 3 of SubQ Selank, started at ~10 units from a 3 mL / 10 mg (~330mcg) vial, and I plan to increase toward about 500 mcg until the 10 mg is finished (Depending how it goes I might keep going up if I decide to stay with SubQ). Then I’ll switch to intranasal and compare route differences. I’ll report back incrementally. Not sure if my rat will try Semax though.

Thanks in advance to anyone willing to share protocols, pitfalls, or negative results too.

My current Theory
Route-to-Phenotype Hypothesis (Selank)
Intranasal and SubQ may not be interchangeable; they may produce different anxiolytic phenotypes.
  • Panic / acute surges: likely favor intranasal due to faster CNS-onset effects (strongest in the ~30-180 min window).
  • Baseline generalized anxiety / chronic nervousness / work-stress reactivity: may favor SubQ because steadier exposure could reduce symptom fluctuation over days to weeks.
  • Performance anxiety: depends on timing goals: intranasal for immediate pre-stressor effect, SubQ for all-day baseline smoothing.
SubQ Research Positioning
SubQ should be studied as a distinct therapeutic profile, not a replacement route:
  • slower onset,
  • potentially steadier background anxiolysis,
  • possibly better for baseline stress tone than rapid interruption of acute spikes.
Click to expand...

Here's some interesting rat data, however the studies are intraperitoneal (IP) Semax/Selank (NOT subQ) and intranasal.
Semax

Semax (rats): IP vs Intranasal
  • Intranasal: Best evidence for direct CNS-linked effects (neurotrophic/signaling and behavioral readouts).
  • IP: Strong systemic neuroprotection/anti-inflammatory effects in injury models; still reaches brain effects, but via systemic exposure.
  • Practical difference: Intranasal is usually chosen for brain-targeted peptide delivery logic; IP is easier for controlled systemic dosing in lab protocols.
Selank (rats): IP vs Intranasal
  • Intranasal: Clear anxiolytic/stress-modulating behavioral evidence.
  • IP: Also shows anti-stress/withdrawal-related effects, but route is systemic and not directly equivalent to nose-to-brain assumptions.
  • Practical difference: Intranasal is more aligned with CNS-focused peptide use; IP is common for reproducible systemic administration.
Bottom line
  • For both Semax and Selank, rat literature supports activity by both routes.
  • The main gap is few true head-to-head IP vs intranasal comparisons in the same study, so cross-paper comparisons are directional, not definitive.
Click to expand...


Russian studies:

As of February 17, 2026, the human dosing reported in Russian clinical use/trials is roughly:
Click to expand...
References:

Semax
  1. Intranasal
  2. Intraperitoneal (IP) / systemic injection models
Selank
  1. Intranasal
  2. Intraperitoneal (IP) / systemic injection models
Click to expand...
 
Last edited:
50+/male research subject. Been running intranasal Semax and Selank (separately) for about 2 months.

Started first week of December with NA-Semax and NA-Selank.

Week 1: 250mcg sprays of each (NA-Semax, NA-Selank) daily in the AM to assess tolerance/side-effects. None observed. Very minor benefits observed (calmness and slightly better focus - but maybe a placebo effect in the begining).

Week 2-4: Doubled the dosage to 500mcg sprays each daily in the AM. Benefits not apparent, no side-effects.

Week 5 - 8: Ran out of NA-Semax and NA-Selank. Reconstituted regular Semax and Selank to compare. Increased the dosage for Semax (400mg - twice per day for a total of 800mcg daily) and kept Selank at around 400-500 mcg daily, switched the schedule Semax in the AM and Selanck in the PM. Minor benefits observed, but not consistent or significantly effective.

Subject is taking a few weeks break now to reset and re-evaulate.

Overall: Can't report significant effect or improvements. Will probably continue to administer until current vials are done; but not sure if it will be something long-term since results are questionable, at least from intranasal for now. Not considering SubQ delivery since original research and source indicated that intranasal should be used.
 
Thanks for the info ...I have Selank and Semax on my research radar, so have been trying to find some researchers that have been using it and anecdotal experiences.
 
Interesting. Responses are so varied. Semax might be my rat's favorite peptide, so far. The boost in the morning before the workday is invigorating. Selank is more subtle, but also has the desired effect. Maybe the 20-day Epitalon run prior to starting primed him for the full effects. He's giving his sinuses a break for a month and then starting an NA Semax cycle to compare. He's thinking about SQ first for two weeks and then IN for 2 more weeks as a comparison.
 
Chili777 said:
Interesting. Responses are so varied. Semax might be my rat's favorite peptide, so far. The boost in the morning before the workday is invigorating. Selank is more subtle, but also has the desired effect. Maybe the 20-day Epitalon run prior to starting primed him for the full effects. He's giving his sinuses a break for a month and then starting an NA Semax cycle to compare. He's thinking about SQ first for two weeks and then IN for 2 more weeks as a comparison.
Click to expand...
Good info, definitely disappointing for my rat. Still looking for that focus/cognitive boost help. What is the Semax dosage you are using on your subject? I need to look into Epitalon, it keeps coming up on my radar.
 
Gorby2025 said:
Good info, definitely disappointing for my rat. Still looking for that focus/cognitive boost help. What is the Semax dosage you are using on your subject? I need to look into Epitalon, it keeps coming up on my radar.
Click to expand...
I made an Epitalon spray also. 500 mcg per spray, 1 mg daily for 20 days. It cleared my COVID brain fog and my vision was sharper and colors were more saturated. I'm 67 and have also had a couple TBIs from car accidents. I think it helped and the fog is better 2 months later. I'm going to continue to cycle that every 3-4 months, although 10 days every month is also a known protocol, I felt I benefited from the longer duration.

I made Semax the same way. 500 mcg per spray for 1 mg daily, although a couple days I did 4 sprays and that gave me a headache. I also have some NA Semax Amidate for next cycle and I'm going to reconstitute that at 350 mcg per spray. I want to compare IN and SQ, but I've read that IN has the best bioavailability.
 
gurbert said:
I’m compiling preclinical (lab rat) observations on Selank and Semax, and would really value input from researchers/experienced testers.

I’m specifically interested in:
  1. Route comparison: SubQ vs intranasal
  2. Compound strategy: Semax alone, Selank alone, vs combined (co-administered)
  3. Outcomes: behavioral/cognitive/anxiety-like effects, and any clear CNS-signaling differences
  4. Practicals: dose range, frequency, timing, washout, and whether route changed effect consistency
  5. Tolerability/signals: local irritation, stress response, habituation/tachyphylaxis, etc.
If you’ve run or seen rat work, I’d appreciate details like:
  • Strain/sex/age (useful but not necessary if your rat is shy)
  • Dosing protocol (mcg, schedule, duration)
  • Route and formulation
  • Whether combo was simultaneous or staggered
Not looking for medical advice, just trying to gather methodologically useful preclinical experience and compare notes across labs.

My current log: my rat is on day 3 of SubQ Selank, started at ~10 units from a 3 mL / 10 mg (~330mcg) vial, and I plan to increase toward about 500 mcg until the 10 mg is finished (Depending how it goes I might keep going up if I decide to stay with SubQ). Then I’ll switch to intranasal and compare route differences. I’ll report back incrementally. Not sure if my rat will try Semax though.

Thanks in advance to anyone willing to share protocols, pitfalls, or negative results too.

My current Theory


Here's some interesting rat data, however the studies are intraperitoneal (IP) Semax/Selank (NOT subQ) and intranasal.
Semax




Russian studies:


References:


Click to expand...
I'm interested in this as well. Recently the old rat started fartin' around with Adamax after he escaped his cage.

Do you have any status updates on how you're feeling with your semax/selank protocols? Thanks!
 
I've made up a spray or Selank, and a spray of Semax. 10ml of saline, 10mg of compound, doing 2x squirts up either side of my nose for a total of 4, which I'm guessing is about 400mcg, and I'm pretty much experiencing no effects whatsoever. I do wish now that I'd split the vials when I got them, set up half of each for nasal, half for subq, so I could test for myself. But after all the reading on here, pretty much everyone was saying nasal is better. I presume I was overdue for a non-respond or a side effect as I've been really lucky so far with zero sides and good responses to everything else I've tried.
 
My spray 20 mg Semax( Standard) and 4 mL sterile saline for 500 mg per spray. So that would be a little light for me too. You could always go up higher to see if you are a complete non-responder.
 
Last edited:
60-year-old male here. Tried IN Semax at a normal starter dose, didn't notice much difference. I think I was expecting something immediate because of brain bioavailability. Stopped for a few weeks.

Then when I paused my KLOW after a 4 week cycle, I missed injecting (you know how we peptide users think), so I groused around in my stash for SOMETHING, ANYTHING I could shoot up, and saw my neglected Semax.

Reconned a vial and injected about 400mcg subQ for 4 days straight. Felt a level of clarity and focus that I hadn't before. Started finishing people's sentences with an eloquence and vocabulary that the speaker could not muster. I'm probably annoying, but don't care. I think that's another benefit of Semax, perhaps undocumented.

I'm out of town now for a few days and didn't bring it with me, so it will be interesting to see if the effect falls off. I intend to continue when I get back home.

Maybe I'll report back after I resume injections, but at that point it's likely my writing will be at a super-human level that many of you won't comprehend anyway. Fair warning.
 
You must log in or register to reply here.

Trending Topics

Latest Posts

Forum Statistics

Threads
18,313
Posts
191,228
Members
61,320
Newest
freedombox
Back
Top Bottom